{"schema":"hottub-news/prospects/v1","item":{"id":"n_lpmmsketradadwocbi5a","title":"First FDA Breakthrough Therapy designation in PSMA PET imaging granted to Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer","title_en":null,"url":"http://www.philippinetimes.com/news/279428860/first-fda-breakthrough-therapy-designation-in-psma-pet-imaging-granted-to-cu-64-sar-bispsma-in-biochemical-recurrence-of-prostate-cancer","outlet":"philippinetimes.com","published":"2026-11-12T18:13:47Z","sponsored":false,"page":"https://hottub.news/articles/n_lpmmsketradadwocbi5a"},"prospects":[{"name":"philippinetimes.com","kind":"organization","role":"outlet","website":"https://philippinetimes.com/","source":"http://www.philippinetimes.com/news/279428860/first-fda-breakthrough-therapy-designation-in-psma-pet-imaging-granted-to-cu-64-sar-bispsma-in-biochemical-recurrence-of-prostate-cancer","note":"Published: First FDA Breakthrough Therapy designation in PSMA PET imaging granted to Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer (2026-11-12)","reason":"Published “First FDA Breakthrough Therapy designation in PSMA PET imaging granted to Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer” on 2026-11-12","group":"Outlet","add_url":"https://crm.joinhottub.com/relationships/add#name=philippinetimes.com&kind=organization&website=https%3A%2F%2Fphilippinetimes.com%2F&source=http%3A%2F%2Fwww.philippinetimes.com%2Fnews%2F279428860%2Ffirst-fda-breakthrough-therapy-designation-in-psma-pet-imaging-granted-to-cu-64-sar-bispsma-in-biochemical-recurrence-of-prostate-cancer&note=Published%3A%20First%20FDA%20Breakthrough%20Therapy%20designation%20in%20PSMA%20PET%20imaging%20granted%20to%20Cu-64%20SAR-bisPSMA%20in%20biochemical%20recurrence%20of%20prostate%20cancer%20%282026-11-12%29","propose":{"name":"philippinetimes.com","kind":"organization","reason":"Published “First FDA Breakthrough Therapy designation in PSMA PET imaging granted to Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer” on 2026-11-12","requestId":"news:n_lpmmsketradadwocbi5a:Outlet:d18b07e0:9f91b841","website":"https://philippinetimes.com/","sourceUrl":"http://www.philippinetimes.com/news/279428860/first-fda-breakthrough-therapy-designation-in-psma-pet-imaging-granted-to-cu-64-sar-bispsma-in-biochemical-recurrence-of-prostate-cancer"}}],"someone_else":{"source":"http://www.philippinetimes.com/news/279428860/first-fda-breakthrough-therapy-designation-in-psma-pet-imaging-granted-to-cu-64-sar-bispsma-in-biochemical-recurrence-of-prostate-cancer","note":"In the news: First FDA Breakthrough Therapy designation in PSMA PET imaging granted to Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer (philippinetimes.com, 2026-11-12)"},"crm":{"name":"CRM by Hottub","add":"Open add_url in a browser: CRM by Hottub's add form, filled in. Nothing is saved until the person presses Add.","mcp":"https://crm.joinhottub.com/api/crm/mcp","tool":"propose_relationship","propose":"If you're connected to CRM by Hottub's MCP server with proposal access, call propose_relationship with `propose` as its arguments. An owner approves it before anything is added. Keep the arguments as given: retries reuse requestId."}}